The University of Chicago Header Logo

Connection

Ayodeji Adegunsoye to Pulmonary Fibrosis

Back to Details
This is a "connection" page, showing publications Ayodeji Adegunsoye has written about Pulmonary Fibrosis.
Ayodeji Adegunsoye
Connection Strength
5.921
Pulmonary Fibrosis
  1. Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nat Commun. 2023 03 17; 14(1):1489.
    View in: PubMed
    Score: 0.760
  2. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
    View in: PubMed
    Score: 0.758
  3. Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population. Arch Bronconeumol. 2022 08; 58(8):590-592.
    View in: PubMed
    Score: 0.687
  4. Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies? Chest. 2021 04; 159(4):1321-1323.
    View in: PubMed
    Score: 0.664
  5. MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis. Thorax. 2019 12; 74(12):1111-1112.
    View in: PubMed
    Score: 0.601
  6. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
    View in: PubMed
    Score: 0.581
  7. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm. 2015; 2015:510105.
    View in: PubMed
    Score: 0.438
  8. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):401-423.
    View in: PubMed
    Score: 0.210
  9. Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis. Ann Am Thorac Soc. 2024 Aug; 21(8):1156-1165.
    View in: PubMed
    Score: 0.209
  10. Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2024 Jan; 63(1).
    View in: PubMed
    Score: 0.201
  11. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
    View in: PubMed
    Score: 0.200
  12. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021 10 16; 398(10309):1450-1460.
    View in: PubMed
    Score: 0.171
  13. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Chest. 2019 05; 155(5):1026-1040.
    View in: PubMed
    Score: 0.142
  14. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
    View in: PubMed
    Score: 0.130
  15. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
    View in: PubMed
    Score: 0.117
  16. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):392-400.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.